Population-based seroprevalence of Neisseria meningitidis serogroup C capsular antibody before the introduction of conjugate vaccine, in Australia.

Backhouse, J L; Gidding, H F; MacIntyre, C R; McIntyre, P B; Gilbert, G L

Backhouse, J L; Gidding, H F; MacIntyre, C R; McIntyre, P B; Gilbert, G L.

Affiliation

Backhouse JL; Centre for Infectious Diseases and Microbiology-Public Health and Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, New South Wales 2145, Australia.

Vaccine ; 25(7): 1310-5, 2007 Jan 26.

Article in En | MEDLINE | ID: mdl-17069937

Subject(s)

Antibodies, Bacterial/analysis; Meningitis, Meningococcal/epidemiology; Meningitis, Meningococcal/immunology; Meningococcal Vaccines/immunology; Neisseria meningitidis, Serogroup C/immunology; Adolescent; Adult; Australia/epidemiology; Bacterial Capsules/immunology; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin G/biosynthesis; Immunoglobulin G/genetics; Infant; Male; Population; Seroepidemiologic Studies; Vaccines, Conjugate/immunology

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Meningococcal Vaccines / Neisseria meningitidis, Serogroup C / Meningitis, Meningococcal / Antibodies, Bacterial Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Oceania Language: En Journal: Vaccine Year: 2007 Document type: Article

Search on Google

XML

PubMed Links